The Presence of Secondary Evans Syndrome in AIDS Patients with Talaromyces marneffei Infection
Authors Wang M, Zhang Z, Yan J, Shi J, Liu S, Wan H
Received 8 January 2021
Accepted for publication 4 March 2021
Published 29 March 2021 Volume 2021:14 Pages 1265—1271
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Suresh Antony
Mengyan Wang, Zhongdong Zhang, Jun Yan, Jinchuan Shi, Shourong Liu, Hu Wan
Department II of Infectious Diseases, Xixi Hospital of Hangzhou, Hangzhou Sixth People’s Hospital, Hangzhou, 310023, People’s Republic of China
Correspondence: Hu Wan; Shourong Liu
Xixi Hospital of Hangzhou, Hangzhou Sixth People’s Hospital, Hangzhou, 310023, People’s Republic of China
Email [email protected]; [email protected]
Objective: Talaromyces marneffei (T.M) is a common opportunistic fungus in human immunodeficiency virus (HIV) infection individual. Secondary Evans syndrome in AIDS patients with Talaromyces marneffei infection has not been reported before. Here, we described cases related to this comorbidity.
Methods: AIDS patients diagnosed with Talaromyces marneffei infection from 2016 to 2020 at Xixi Hospital of Hangzhou were included in this retrospective study.
Results: Total 76 AIDS patients with T.M infection were enrolled. The most common symptoms were fever and cough (70/76; 55/76, respectively). 53/76 (69.74%) patients got positive results of direct antiglobulin test. 14/76 AIDS-T.M patients combined with secondary Hemophagocytic lymphohistiocytosis (HLH). Five patients were diagnosed with AIDS-T.M associated Evans syndrome. There were severe inflammatory reaction, liver dysfunction, coagulation dysfunction and immunodeficiency status in AIDS-T.M patients with secondary Evans syndrome. All patients received antifungal therapy and three patients received corticosteroids for Evans syndrome treatment. One patient died due to sepsis.
Conclusion: AIDS-T.M patients with secondary Evans syndrome is extremely rare and we need to be alert to the occurrence of secondary Evans syndrome in AIDS-T.M patients. Clinicians should timely start effective antifungal treatments with suspicious T.M infection in AIDS patients.
Keywords: Talaromyces marneffei, Evans syndrome, human immunodeficiency virus, clinical characteristics
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]